Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Walbrzych – page 3

48 clinical trials in Walbrzych, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Walbrzych at a glance
48
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

48 trials in Walbrzych

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
  • Sponsor:Ryvu Therapeutics S.A.
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen - Cilag International
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Romiplostim
  • Sponsor:Amgen Inc.
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Viridian Therapeutics Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Eyepoint Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Celltrion Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Celgene Corp.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Luspatercept
  • Sponsor:Celgene Corp.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Luspatercept
  • Sponsor:Celgene Corp.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Viridian Therapeutics Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:BeOne Medicines AG

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Walbrzych

What the registry says about research in the country

01 Hematologic Malignancies

Groundbreaking research focusing on multiple myeloma and leukemia treatments, including novel combination therapies and targeted approaches for both newly diagnosed and relapsed/refractory cases.

  • Multiple Myeloma Studies
  • Acute Myeloid Leukemia Trials
  • Chronic Lymphocytic Leukemia Research

Several trials are evaluating innovative drug combinations to improve patient outcomes and survival rates.

02 Lymphoma Research

Comprehensive studies investigating treatments for various lymphoma types, with particular emphasis on follicular lymphoma and diffuse large B-cell lymphoma.

  • Novel Antibody Therapies
  • Combination Treatment Approaches
  • Comparative Effectiveness Studies

Research focuses on comparing new therapeutic options against current standard treatments.

03 Blood Disorders

Innovative trials examining treatments for myelodysplastic syndrome and myeloproliferative disorders, including studies of novel agents for anemia management.

  • Myelofibrosis Studies
  • Polycythemia Vera Research
  • Lower-Risk MDS Treatments

These studies aim to improve quality of life and treatment outcomes for patients with various blood disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.